Publication | Open Access

Experience in daily practice with ipilimumab for the treatment of patients with metastatic melanoma: an early increase in lymphocyte and eosinophil counts is associated with improved survival

Improved SurvivalMedicineMelanomaImmunologyMetastatic MelanomaDaily PracticeImmune Checkpoint InhibitorMetronomic ChemotherapyDermatologyImmunotherapyOncologySkin Cancer